0001192482-19-000430.txt : 20191113 0001192482-19-000430.hdr.sgml : 20191113 20191113210335 ACCESSION NUMBER: 0001192482-19-000430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191108 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quaker BioVentures II LP CENTRAL INDEX KEY: 0001497725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 191216010 BUSINESS ADDRESS: STREET 1: QUAKER BIOVENTURES STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (215) 988-6800 MAIL ADDRESS: STREET 1: QUAKER BIOVENTURES STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quaker BioVentures Capital II, L.P. CENTRAL INDEX KEY: 0001583083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 191216011 BUSINESS ADDRESS: STREET 1: CIRA CENTER STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-988-6800 MAIL ADDRESS: STREET 1: CIRA CENTER STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TELA Bio, Inc. CENTRAL INDEX KEY: 0001561921 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455320061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-320-2930 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-11-08 0001561921 TELA Bio, Inc. TELA 0001497725 Quaker BioVentures II LP 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004 0 0 1 0 0001583083 Quaker BioVentures Capital II, L.P. 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004 0 0 1 0 Common Stock 2019-11-08 4 P 0 153846 13.00 A 888664 D Common Stock 2019-11-13 4 C 0 345489 A 1234153 D Common Stock 2019-11-13 4 C 0 516947 A 1751100 D Series A Preferred Stock 2019-11-13 4 C 0 8530145 0 D Common Stock 345489 0 D Series B Preferred Stock 2019-11-13 4 C 0 12763434 0 D Common Stock 516947 0 D Warrant (right to buy) 1.16 2019-11-13 4 C 0 446813 0 D 2017-01-18 2027-01-18 Series B Preferred Stock 446813 0 D Warrant (right to buy) 28.65 2019-11-13 4 C 0 446813 0 D 2019-11-13 2027-01-18 Common Stock 18096 446813 D Reflects 705,530 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a). Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date. Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date. Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019. Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering. Quaker BioVentures II, L.P. By: Quaker Bioventures Capital II, L.P., its general partner By Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager 2019-11-13 Quaker Bioventures Capital II, L.P., its general partner By: Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager 2019-11-13